
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) through any online brokerage.
There are no as such competitors for Global X Genomics & Biotechnology ETF.
There is no analysis for Global X Genomics & Biotechnology ETF to provide a consensus price target.
The stock price for Global X Genomics & Biotechnology ETF (NASDAQ: GNOM) is $43.69 last updated May 19, 2026 at 8:14 AM EDT.
There are no upcoming dividends for Global X Genomics & Biotechnology ETF.
Global X Genomics & Biotechnology ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Global X Genomics & Biotechnology ETF.
| Sector | Healthcare |
| Category | High Performer-Mid Growth |
| Investment Style | Mid Cap Growth |
| Fund Inception | Apr 5, 2019 |
| Managers | Nam To Sandy Lu Wayne Xie Vanessa Yang |
| Definition | This equity fund portfolio contains majority of stocks with strong financial performance and average growth potential |
| Symbol | Name | Share % |
|---|---|---|
| TECH | Bio-Techne Corp | 3.47% |
| ARWR | Arrowhead Pharmaceutic... | 6.41% |
| NTRA | Natera Inc | 4.27% |
| MRNA | Moderna Inc | 8.46% |
| ILMN | Illumina, Inc. | 5.34% |
| BMRN | Biomarin Pharmaceutica... | 4.48% |
| GH | Guardant Health Inc | 5.26% |
| VRTX | Vertex Pharmaceuticals... | 4.40% |
| PRAX | Praxis Precision Medic... | 6.77% |
| FF | Biontech Se Adr | 3.54% |
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.